Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$21.58 - $29.5 $370,571 - $506,574
-17,172 Reduced 27.43%
45,424 $1.23 Million
Q3 2023

Nov 02, 2023

SELL
$25.8 - $39.97 $124,923 - $193,534
-4,842 Reduced 7.18%
62,596 $1.86 Million
Q2 2023

Aug 07, 2023

SELL
$20.94 - $38.01 $87,256 - $158,387
-4,167 Reduced 5.82%
67,438 $2.41 Million
Q1 2023

May 09, 2023

SELL
$22.92 - $33.76 $130,919 - $192,837
-5,712 Reduced 7.39%
71,605 $1.68 Million
Q4 2022

Feb 07, 2023

BUY
$25.44 - $59.78 $525,921 - $1.24 Million
20,673 Added 36.5%
77,317 $2.1 Million
Q3 2022

Nov 03, 2022

BUY
$43.66 - $61.0 $2.47 Million - $3.46 Million
56,644 New
56,644 $3.05 Million
Q2 2022

Nov 18, 2022

BUY
$28.82 - $77.35 $2,709 - $7,270
94 Added 0.16%
58,203 $2.36 Million
Q1 2022

Nov 18, 2022

BUY
$48.25 - $100.49 $1.42 Million - $2.95 Million
29,359 Added 102.12%
58,109 $3.85 Million
Q4 2021

Nov 18, 2022

SELL
$88.71 - $120.43 $43,645 - $59,251
-492 Reduced 1.68%
28,750 $2.88 Million
Q3 2021

Nov 18, 2022

SELL
$98.77 - $132.17 $13,531 - $18,107
-137 Reduced 0.47%
29,242 $3.66 Million
Q2 2021

Nov 18, 2022

BUY
$109.77 - $165.68 $172,448 - $260,283
1,571 Added 5.65%
29,379 $3.65 Million
Q1 2021

Nov 18, 2022

SELL
$127.04 - $179.1 $92,358 - $130,205
-727 Reduced 2.55%
27,808 $4.25 Million
Q4 2020

Nov 18, 2022

SELL
$99.96 - $135.93 $75,669 - $102,899
-757 Reduced 2.58%
28,535 $3.68 Million
Q3 2020

Nov 18, 2022

SELL
$80.32 - $111.8 $2.2 Million - $3.06 Million
-27,352 Reduced 48.29%
29,292 $3.28 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Citizens Business Bank Portfolio

Follow Citizens Business Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.